CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of GX-03 topical ointment in adult subjects with atopic dermatitis (eczema).Stage 1 (Completed):Stage 1 comprised an initial cohort of 50 su...
Phase 2, Phase 3
Irving, Texas, United States
in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common sk...
Phase 3
Dallas, Texas, United States and 22 other locations
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...
Phase 2
Southlake, Texas, United States and 22 other locations
in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...
Phase 3
Dallas, Texas, United States and 49 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Southlake, Texas, United States and 39 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Frisco, Texas, United States and 27 other locations
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...
Phase 3
Dallas, Texas, United States and 48 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
Dallas, Texas, United States and 88 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Dallas, Texas, United States and 60 other locations
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2
Dallas, Texas, United States and 36 other locations
Clinical trials
Research sites
Resources
Legal